TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12466022
log Bayes Factor = <0.0001
Chromosome 2   position 43,359,061  (GRCh37) Explore rs12466022 on Ensembl!
Variant rs12466022 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D46.9 Myelodysplastic syndrome, unspecified
0.019 0.981 0.000
D46 Myelodysplastic syndromes
0.018 0.982 0.000
D46.2 Refractory anaemia with excess of blasts
0.018 0.982 0.000
M23.3 Other meniscus derangements
0.017 0.983 0.000
M23.33 Other meniscus derangements (Medial collateral ligament or Other and unspecified medial meniscus)
0.017 0.983 0.000
M23.36 Other meniscus derangements (Other and unspecified lateral meniscus)
0.017 0.983 0.000
D46.7 Other myelodysplastic syndromes
0.016 0.984 0.000
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.016 0.984 0.000
D46.1 Refractory anaemia with sideroblasts
0.016 0.984 0.000
M23.34 Other meniscus derangements (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.016 0.984 0.000
M23.8 Other internal derangements of knee
0.015 0.985 0.000
D46.4 Refractory anaemia, unspecified
0.014 0.985 0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction
0.014 0.986 0.000
M23.30 Other meniscus derangements (Multiple sites)
0.014 0.986 0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.013 0.986 0.000
D46.5 Refractory anaemia with multi-lineage dysplasia
0.013 0.986 0.000
D46.3 Refractory anaemia with excess of blasts with transformation
0.013 0.986 0.000
D46.0 Refractory anaemia without sideroblasts, so stated
0.013 0.986 0.000
I69.3 Sequelae of cerebral infarction
0.013 0.986 0.000
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)
0.013 0.987 0.000
T84.1 Mechanical complication of internal fixation device of bones of limb
0.013 0.987 0.000
M23 Internal derangement of knee
0.013 0.987 0.000
I69 Sequelae of cerebrovascular disease
0.013 0.987 0.000
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.013 0.987 0.000
M23.37 Other meniscus derangements-Capsular lig
0.012 0.988 0.000
M23.82 Other internal derangements of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.012 0.988 0.000
C34.1 Upper lobe, bronchus or lung
0.000 0.988 0.012
C34 Malignant neoplasm of bronchus and lung
0.000 0.988 0.012
C34.9 Bronchus or lung, unspecified
0.000 0.988 0.012
M23.80 Other internal derangements of knee (Multiple sites)
0.012 0.988 0.000
Y40.9 Systemic antibiotic, unspecified
0.012 0.988 0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)
0.012 0.988 0.000
C34.3 Lower lobe, bronchus or lung
0.000 0.988 0.012
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.011 0.988 0.000
Y52 Agents primarily affecting the cardiovascular system
0.011 0.989 0.000
M23.83 Other internal derangements of knee (Medial collateral ligament or Other and unspecified medial meniscus)
0.011 0.989 0.000
I69.0 Sequelae of subarachnoid haemorrhage
0.011 0.989 0.000
Y40 Systemic antibiotics
0.011 0.989 0.000
M23.87 Other internal derangements of knee (Capsular ligament)
0.011 0.989 0.000
M23.85 Other internal derangements of knee (Posterior horn of lateral meniscus)
0.011 0.989 0.000
M23.6 Other spontaneous disruption of ligament(s) of knee
0.011 0.989 0.000
M23.84 Other internal derangements of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.010 0.989 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.011 0.989 0.000
M23.1 Discoid meniscus (congenital)
0.010 0.990 0.000
M23.5 Chronic instability of knee
0.010 0.990 0.000
M23.86 Other internal derangements of knee (Other and unspecified lateral meniscus)
0.010 0.990 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.010 0.990 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.010 0.990 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.010 0.990 0.000
Y52.1 Calcium-channel blockers
0.010 0.990 0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.009 0.990 0.000
M23.4 Loose body in knee
0.009 0.991 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.009 0.991 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.009 0.991 0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.009 0.991 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.009 0.991 0.000
M23.61 Other spontaneous disruption of ligament(s) of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.009 0.991 0.000
Y40.0 Penicillins
0.009 0.991 0.000
Y40.4 Tetracyclines
0.009 0.991 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.009 0.991 0.000
Y40.6 Rifamycins
0.008 0.991 0.000
C34.8 Overlapping lesion of bronchus and lung
0.000 0.991 0.008
Y49 Psychotropic drugs, not elsewhere classified
0.008 0.991 0.000
M23.16 Discoid meniscus (congenital) (Other and unspecified lateral meniscus)
0.008 0.991 0.000
M23.0 Cystic meniscus
0.008 0.991 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.008 0.992 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.008 0.992 0.000
Y52.7 Peripheral vasodilators
0.008 0.992 0.000
Y40.7 Antifungal antibiotics, systemically used
0.008 0.992 0.000
Y40.2 Chloramphenicol group
0.008 0.992 0.000
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)
0.008 0.992 0.000
Y40.8 Other systemic antibiotics
0.008 0.992 0.000
Y40.5 Aminoglycosides
0.008 0.992 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.008 0.992 0.000
K42.0 Umbilical hernia with obstruction, without gangrene
0.000 0.992 0.008
M23.41 Loose body in knee-Ant lig/hrn men
0.008 0.992 0.000
M23.69 Other spontaneous disruption of ligament(s) of knee (Unspecified ligament or Unspecified meniscus)
0.008 0.992 0.000
M23.67 Other spontaneous disruption of ligament(s) of knee (Capsular ligament)
0.008 0.992 0.000
M23.66 Other spontaneous disruption of ligament(s) of knee-O/unsp
0.008 0.992 0.000
M23.65 Other spontaneous disruption of ligament(s) of knee-Pst hrn
0.008 0.992 0.000
M23.64 Other spontaneous disruption of ligament(s) of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.008 0.992 0.000
M23.63 Other spontaneous disruption of ligament(s) of knee (Medial collateral ligament or Other and unspecified medial meniscus)
0.008 0.992 0.000
M23.62 Other spontaneous disruption of ligament(s) of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.008 0.992 0.000
M23.60 Other spontaneous disruption of ligament(s) of knee (Multiple sites)
0.008 0.992 0.000
Y40.3 Macrolides
0.008 0.992 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.008 0.992 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.008 0.992 0.000
Y41.0 Sulphonamides
0.008 0.992 0.000
M23.19 Discoid meniscus (congenital) (Unspecified ligament or Unspecified meniscus)
0.008 0.992 0.000
M23.17 Discoid meniscus (congenital)-Capsular lig
0.008 0.992 0.000
M23.15 Discoid meniscus (congenital) (Posterior horn of lateral meniscus)
0.008 0.992 0.000
M23.14 Discoid meniscus (congenital) (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.008 0.992 0.000
M23.13 Discoid meniscus (congenital) (Medial collateral ligament or Other and unspecified medial meniscus)
0.008 0.992 0.000
M23.12 Discoid meniscus (congenital) (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.008 0.992 0.000
M23.11 Discoid meniscus (congenital) (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.008 0.992 0.000
M23.10 Discoid meniscus (congenital) (Multiple sites)
0.008 0.992 0.000
M23.57 Chronic instability of knee (Capsular ligament)
0.008 0.992 0.000
M23.56 Chronic instability of knee (Other and unspecified lateral meniscus)
0.008 0.992 0.000
M23.55 Chronic instability of knee (Posterior horn of lateral meniscus)
0.008 0.992 0.000
M23.54 Chronic instability of knee (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.008 0.992 0.000
M23.53 Chronic instability of knee (Medial collateral ligament or Other and unspecified medial meniscus)
0.008 0.992 0.000
M23.52 Chronic instability of knee (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.008 0.992 0.000
M23.50 Chronic instability of knee (Multiple sites)
0.008 0.992 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.000 0.992 0.008
M23.32 Other meniscus derangements (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.008 0.992 0.000
M23.46 Loose body in knee-O/unsp lat men
0.007 0.992 0.000
C34.2 Middle lobe, bronchus or lung
0.000 0.992 0.007
Y47 Sedatives, hypnotics and antianxiety drugs
0.007 0.993 0.000
M23.9 Internal derangement of knee, unspecified
0.007 0.993 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.000 0.993 0.007
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.007 0.993 0.000
C30.0 Nasal cavity
0.000 0.993 0.007
Y58 Bacterial vaccines
0.007 0.993 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.007 0.993 0.000
Y49.5 Other antipsychotics and neuroleptics
0.007 0.993 0.000
Y44 Agents primarily affecting blood constituents
0.007 0.993 0.000
L03.3 Cellulitis of trunk
0.000 0.993 0.007
M23.47 Loose body in knee-Capsular lig
0.007 0.993 0.000
M23.45 Loose body in knee-Pst hrn lat men
0.007 0.993 0.000
M23.44 Loose body in knee-Lat lig/ant men
0.007 0.993 0.000
M23.42 Loose body in knee-Pst lig/hrn men
0.007 0.993 0.000
M23.40 Loose body in knee-Mult sites
0.007 0.993 0.000
M23.03 Cystic meniscus (Medial collateral ligament or Other and unspecified medial meniscus)
0.007 0.993 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.007 0.993 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.007 0.993 0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.007 0.993 0.000
Y53.4 Other laxatives
0.007 0.993 0.000
M40.24 Other and unspecified kyphosis (Thoracic region)
0.007 0.993 0.000
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)
0.007 0.993 0.000
Y59 Other and unspecified vaccines and biological substances
0.006 0.993 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.007 0.993 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.006 0.993 0.000
Y53.7 Emetics
0.006 0.993 0.000
Y53.6 Antidiarrhoeal drugs
0.006 0.993 0.000
Y53.5 Digestants
0.006 0.993 0.000
Y53.3 Saline and osmotic laxatives
0.006 0.993 0.000
Y53.2 Stimulant laxatives
0.006 0.993 0.000
Y53.0 Histamine H2-receptor antagonists
0.006 0.993 0.000
M23.59 Chronic instability of knee (Unspecified ligament or Unspecified meniscus)
0.006 0.993 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.000 0.993 0.006
C34.0 Main bronchus
0.000 0.994 0.006
Y46 Antiepileptics and anti-Parkinsonism drugs
0.006 0.994 0.000
Y49.9 Psychotropic drug, unspecified
0.006 0.994 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.006 0.994 0.000
Y49.7 Psychostimulants with abuse potential
0.006 0.994 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.006 0.994 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.006 0.994 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.006 0.994 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.006 0.994 0.000
M23.07 Cystic meniscus-Capsular lig
0.006 0.994 0.000
M23.05 Cystic meniscus (Posterior horn of lateral meniscus)
0.006 0.994 0.000
M23.02 Cystic meniscus (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.006 0.994 0.000
M23.01 Cystic meniscus (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.006 0.994 0.000
M23.00 Cystic meniscus (Multiple sites)
0.006 0.994 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.006 0.994 0.000
Y41.4 Anthelminthics
0.006 0.994 0.000
Y41.3 Other antiprotozoal drugs
0.006 0.994 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.006 0.994 0.000
Y41.1 Antimycobacterial drugs
0.006 0.994 0.000
Y44.5 Thrombolytic drugs
0.006 0.994 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.006 0.994 0.000
M23.04 Cystic meniscus (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.006 0.994 0.000
Y48 Anaesthetics and therapeutic gases
0.006 0.994 0.000
Y47.1 Benzodiazepines
0.006 0.994 0.000
C37 Malignant neoplasm of thymus
0.000 0.994 0.006
M23.09 Cystic meniscus (Unspecified ligament or Unspecified meniscus)
0.006 0.994 0.000
M23.43 Loose body in knee-Med lig/oth men
0.006 0.994 0.000
M65.9 Synovitis and tenosynovitis, unspecified
0.006 0.994 0.000
Y49.2 Other and unspecified antidepressants
0.006 0.994 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.006 0.994 0.000
Y43.1 Antineoplastic antimetabolites
0.006 0.994 0.000
C38.4 Pleura
0.000 0.994 0.006
M23.49 Loose body in knee-Unspec lig/men
0.006 0.994 0.000
Z80.4 Family history of malignant neoplasm of genital organs
0.006 0.994 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.000 0.994 0.006
C31 Malignant neoplasm of accessory sinuses
0.000 0.994 0.006
Y41.5 Antiviral drugs
0.005 0.994 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.005 0.994 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.005 0.994 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.005 0.994 0.000
Y47.4 Bromine compounds
0.005 0.994 0.000
Y47.3 Paraldehyde
0.005 0.994 0.000
Y47.2 Chloral derivatives
0.005 0.994 0.000
Y47.0 Barbiturates, not elsewhere classified
0.005 0.994 0.000
H44.2 Degenerative myopia
0.000 0.994 0.006
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.005 0.994 0.000
Y58.0 BCG vaccine
0.005 0.994 0.000
M23.97 Internal derangement of knee, unspecified (Capsular ligament)
0.005 0.994 0.000
M23.96 Internal derangement of knee, unspecified (Other and unspecified lateral meniscus)
0.005 0.994 0.000
M23.95 Internal derangement of knee, unspecified (Posterior horn of lateral meniscus)
0.005 0.994 0.000
M23.94 Internal derangement of knee, unspecified (Lateral collateral ligament or Anterior horn of lateral meniscus)
0.005 0.994 0.000
M23.92 Internal derangement of knee, unspecified (Posterior cruciate ligament or Posterior horn of medial meniscus)
0.005 0.994 0.000
M23.91 Internal derangement of knee, unspecified (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.005 0.994 0.000
M23.90 Internal derangement of knee, unspecified (Multiple sites)
0.005 0.994 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.994 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.005 0.994 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.994 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.994 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.994 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.005 0.994 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.994 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.005 0.994 0.000
Y51.0 Anticholinesterase agents
0.005 0.994 0.000
C30.1 Middle ear
0.000 0.994 0.005
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.005 0.994 0.000
Y55.5 Anticommon cold drugs
0.005 0.994 0.000
Y55.4 Expectorants
0.005 0.994 0.000
Y55.3 Antitussives
0.005 0.994 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.005 0.994 0.000
Y55.0 Oxytocic drugs
0.005 0.994 0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.005 0.994 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.005 0.994 0.000
C33 Malignant neoplasm of trachea
0.000 0.995 0.005
Y58.9 Other and unspecified bacterial vaccines
0.005 0.995 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.005 0.995 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.005 0.995 0.000
Y58.5 Diphtheria vaccine
0.005 0.995 0.000
Y58.4 Tetanus vaccine
0.005 0.995 0.000
Y58.3 Plague vaccine
0.005 0.995 0.000
Y58.2 Cholera vaccine
0.005 0.995 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.005 0.995 0.000
E03.9 Hypothyroidism, unspecified
0.000 0.995 0.005
Y44.9 Other and unspecified agents affecting blood constituents
0.005 0.995 0.000
Y44.7 Plasma substitutes
0.005 0.995 0.000
Y44.6 Natural blood and blood products
0.005 0.995 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.005 0.995 0.000
Y50.9 Central nervous system stimulant, unspecified
0.005 0.995 0.000
Y50.8 Other central nervous system stimulants
0.005 0.995 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.005 0.995 0.000
Y50.1 Opioid receptor antagonists
0.005 0.995 0.000
Y50.0 Analeptics
0.005 0.995 0.000
M40.2 Other and unspecified kyphosis
0.005 0.995 0.000
Y43 Primarily systemic agents
0.005 0.995 0.000
G81.9 Hemiplegia, unspecified
0.005 0.995 0.000
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)
0.005 0.995 0.000
Y46.6 Other and unspecified antiepileptics
0.005 0.995 0.000
E83.4 Disorders of magnesium metabolism
0.000 0.995 0.005
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.005 0.995 0.000
Y48.4 Anaesthetic, unspecified
0.005 0.995 0.000
Y59.9 Vaccine or biological substance, unspecified
0.005 0.995 0.000
Y59.8 Other specified vaccines and biological substances
0.005 0.995 0.000
Y59.2 Protozoal vaccines
0.005 0.995 0.000
Y59.1 Rickettsial vaccines
0.005 0.995 0.000
Y59.0 Viral vaccines
0.005 0.995 0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)
0.005 0.995 0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura
0.000 0.995 0.005
C38.2 Posterior mediastinum
0.000 0.995 0.005
C38.1 Anterior mediastinum
0.000 0.995 0.005
C38.0 Heart
0.000 0.995 0.005
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.005 0.995 0.000
Y46.8 Antispasticity drugs
0.005 0.995 0.000
Y46.7 Anti-Parkinsonism drugs
0.005 0.995 0.000
Y46.5 Valproic acid
0.005 0.995 0.000
Y46.3 Deoxybarbiturates
0.005 0.995 0.000
Y46.1 Oxazolidinediones
0.005 0.995 0.000
Y46.0 Succinimides
0.005 0.995 0.000
C44.6 Skin of upper limb, including shoulder
0.000 0.995 0.005
Y57 Other and unspecified drugs and medicaments
0.005 0.995 0.000
N73.6 Female pelvic peritoneal adhesions
0.000 0.995 0.005
Y56.9 Topical agent, unspecified
0.005 0.995 0.000
Y56.8 Other topical agents
0.005 0.995 0.000
Y56.7 Dental drugs, topically applied
0.005 0.995 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.005 0.995 0.000
Y56.5 Ophthalmological drugs and preparations
0.005 0.995 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.005 0.995 0.000
Y56.3 Emollients, demulcents and protectants
0.005 0.995 0.000
Y56.2 Local astringents and local detergents
0.005 0.995 0.000
Y56.1 Antipruritics
0.005 0.995 0.000
M23.06 Cystic meniscus (Other and unspecified lateral meniscus)
0.004 0.995 0.000
Y48.2 Other and unspecified general anaesthetics
0.005 0.995 0.000
Z86.0 Personal history of other neoplasms
0.000 0.995 0.005
C38.3 Mediastinum, part unspecified
0.000 0.995 0.005
Y48.5 Therapeutic gases
0.005 0.995 0.000
Y48.1 Parenteral anaesthetics
0.005 0.995 0.000
Y48.0 Inhaled anaesthetics
0.005 0.995 0.000
M23.99 Internal derangement of knee, unspecified (Unspecified ligament or Unspecified meniscus)
0.004 0.995 0.000
Y46.2 Hydantoin derivatives
0.005 0.995 0.000
M23.93 Internal derangement of knee, unspecified (Medial collateral ligament or Other and unspecified medial meniscus)
0.004 0.995 0.000
N04.9 Unspecified
0.005 0.995 0.000
Y59.3 Immunoglobulin
0.004 0.995 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.005 0.995 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.005 0.995 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.995 0.000
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.004 0.995 0.000
M81.40 Drug-induced osteoporosis (Multiple sites)
0.000 0.995 0.005
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.004 0.995 0.000
M19.17 Post-traumatic arthrosis of other joints (Ankle and foot)
0.004 0.995 0.000
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.004 0.995 0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.004 0.996 0.000
M40.22 Other and unspecified kyphosis (Cervical region)
0.004 0.996 0.000
C31.9 Accessory sinus, unspecified
0.000 0.996 0.004
C31.8 Overlapping lesion of accessory sinuses
0.000 0.996 0.004
C31.3 Sphenoidal sinus
0.000 0.996 0.004
C31.2 Frontal sinus
0.000 0.996 0.004
C31.1 Ethmoidal sinus
0.000 0.996 0.004
C31.0 Maxillary sinus
0.000 0.996 0.004
C39.9 Ill-defined sites within the respiratory system
0.000 0.996 0.004
C39.8 Overlapping lesion of respiratory and intrathoracic organs
0.000 0.996 0.004
C39.0 Upper respiratory tract, part unspecified
0.000 0.996 0.004
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)
0.004 0.996 0.000
C32 Malignant neoplasm of larynx
0.000 0.996 0.004
R09.1 Pleurisy
0.000 0.996 0.004
M40 Kyphosis and lordosis
0.004 0.996 0.000
Y46.4 Iminostilbenes
0.004 0.996 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.004 0.996 0.000
Y57.6 Other diagnostic agents
0.004 0.996 0.000
M40.28 Other and unspecified kyphosis (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M40.27 Other and unspecified kyphosis (Lumbosacral region)
0.004 0.996 0.000
M40.25 Other and unspecified kyphosis (Thoracolumbar region)
0.004 0.996 0.000
M40.23 Other and unspecified kyphosis (Cervicothoracic region)
0.004 0.996 0.000
M40.21 Other and unspecified kyphosis (Occipito-atlanto-axial region)
0.004 0.996 0.000
M40.20 Other and unspecified kyphosis (Multiple sites in spine)
0.004 0.996 0.000
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.004 0.996 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
Y43.9 Primarily systemic agent, unspecified
0.004 0.996 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.004 0.996 0.000
Y43.6 Enzymes, not elsewhere classified
0.004 0.996 0.000
Y43.5 Acidifying and alkalising agents
0.004 0.996 0.000
Y43.2 Antineoplastic natural products
0.004 0.996 0.000
M81.90 Osteoporosis, unspecified (Multiple sites)
0.000 0.996 0.004
M43 Other deforming dorsopathies
0.004 0.996 0.000
M40.26 Other and unspecified kyphosis (Lumbar region)
0.004 0.996 0.000
M43.1 Spondylolisthesis
0.004 0.996 0.000
M43.19 Spondylolisthesis (Site unspecified)
0.004 0.996 0.000
Y42.1 Thyroid hormones and substitutes
0.004 0.996 0.000
Y44.2 Anticoagulants
0.004 0.996 0.000
M43.16 Spondylolisthesis (Lumbar region)
0.004 0.996 0.000
Y54.7 Agents affecting calcification
0.004 0.996 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.003 0.996 0.000
Y57.7 Vitamins, not elsewhere classified
0.004 0.996 0.000
Y57.4 Pharmaceutical excipients
0.004 0.996 0.000
Y57.3 Alcohol deterrents
0.004 0.996 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.004 0.996 0.000
Y57.1 Lipotropic drugs
0.004 0.996 0.000
Y57.0 Appetite depressants [anorectics]
0.004 0.996 0.000
N04 Nephrotic syndrome
0.004 0.996 0.000
M43.0 Spondylolysis
0.004 0.996 0.000
Y54.9 Mineral salts, not elsewhere classified
0.003 0.996 0.000
Y54.8 Agents affecting uric acid metabolism
0.003 0.996 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.003 0.996 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.003 0.996 0.000
Y54.0 Mineralocorticoids
0.003 0.996 0.000
M81.4 Drug-induced osteoporosis
0.000 0.996 0.004
Y43.0 Antiallergic and antiemetic drugs
0.003 0.996 0.000
M40.29 Other and unspecified kyphosis (Site unspecified)
0.003 0.996 0.000
M40-M43 Deforming dorsopathies
0.004 0.996 0.000
Y42.9 Other and unspecified hormone antagonists
0.003 0.996 0.000
Y42.4 Oral contraceptives
0.003 0.996 0.000
Y57.8 Other drugs and medicaments
0.003 0.996 0.000
H20.9 Iridocyclitis, unspecified
0.000 0.996 0.003
Y42.2 Antithyroid drugs
0.003 0.997 0.000
H44.0 Purulent endophthalmitis
0.000 0.997 0.003
M81.49 Drug-induced osteoporosis (Site unspecified)
0.000 0.997 0.003
Y54.4 Loop [high-ceiling] diuretics
0.003 0.997 0.000
H44 Disorders of globe
0.000 0.997 0.003
M43.8 Other specified deforming dorsopathies
0.003 0.997 0.000
Y48.3 Local anaesthetics
0.003 0.997 0.000
N04.0 Minor glomerular abnormality
0.003 0.997 0.000
G81 Hemiplegia
0.003 0.997 0.000
C32.8 Overlapping lesion of larynx
0.000 0.997 0.003
C32.3 Laryngeal cartilage
0.000 0.997 0.003
C32.2 Subglottis
0.000 0.997 0.003
C32.0 Glottis
0.000 0.997 0.003
J03.9 Acute tonsillitis, unspecified
0.003 0.997 0.000
M40.4 Other lordosis
0.003 0.997 0.000
M40.3 Flatback syndrome
0.003 0.997 0.000
M40.1 Other secondary kyphosis
0.003 0.997 0.000
M40.0 Postural kyphosis
0.003 0.997 0.000
M43.02 Spondylolysis (Cervical region)
0.003 0.997 0.000
Q61.3 Polycystic kidney, unspecified
0.003 0.997 0.000
M40.5 Lordosis, unspecified
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.003 0.997 0.000
G81.1 Spastic hemiplegia
0.003 0.997 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.003 0.997 0.000
M43.06 Spondylolysis (Lumbar region)
0.003 0.997 0.000
M43.2 Other fusion of spine
0.003 0.997 0.000
M41 Scoliosis
0.003 0.997 0.000
N73 Other female pelvic inflammatory diseases
0.000 0.997 0.003
N04.1 Focal and segmental glomerular lesions
0.003 0.997 0.000
M43.9 Deforming dorsopathy, unspecified
0.003 0.997 0.000
M43.5 Other recurrent vertebral subluxation
0.003 0.997 0.000
M43.4 Other recurrent atlantoaxial subluxation
0.003 0.997 0.000
M43.3 Recurrent atlantoaxial subluxation with myelopathy
0.003 0.997 0.000
M43.18 Spondylolisthesis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M43.15 Spondylolisthesis (Thoracolumbar region)
0.003 0.997 0.000
M43.14 Spondylolisthesis (Thoracic region)
0.003 0.997 0.000
M43.13 Spondylolisthesis (Cervicothoracic region)
0.003 0.997 0.000
M43.11 Spondylolisthesis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M43.10 Spondylolisthesis (Multiple sites in spine)
0.003 0.997 0.000
M43.12 Spondylolisthesis (Cervical region)
0.003 0.997 0.000
C02.9 Tongue, unspecified
0.003 0.997 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.997 0.000
M43.86 Other specified deforming dorsopathies (Lumbar region)
0.003 0.997 0.000
N04.2 Diffuse membranous glomerulonephritis
0.003 0.997 0.000
N73.0 Acute parametritis and pelvic cellulitis
0.000 0.997 0.003
I63.9 Cerebral infarction, unspecified
0.003 0.997 0.000
N04.8 Other
0.003 0.997 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.003 0.997 0.000
N04.6 Dense deposit disease
0.003 0.997 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.003 0.997 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.003 0.997 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.003 0.997 0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)
0.003 0.997 0.000
M43.07 Spondylolysis (Lumbosacral region)
0.003 0.997 0.000
M43.05 Spondylolysis (Thoracolumbar region)
0.003 0.997 0.000
M43.04 Spondylolysis (Thoracic region)
0.003 0.997 0.000
M43.03 Spondylolysis (Cervicothoracic region)
0.003 0.997 0.000
M43.01 Spondylolysis (Occipito-atlanto-axial region)
0.003 0.997 0.000
M43.00 Spondylolysis (Multiple sites in spine)
0.003 0.997 0.000
M81.48 Drug-induced osteoporosis (Other)
0.000 0.997 0.003
M81.47 Drug-induced osteoporosis (Ankle and foot)
0.000 0.997 0.003
M81.46 Drug-induced osteoporosis (Lower leg)
0.000 0.997 0.003
M81.45 Drug-induced osteoporosis (Pelvic region and thigh)
0.000 0.997 0.003
M81.44 Drug-induced osteoporosis (Hand)
0.000 0.997 0.003
M81.43 Drug-induced osteoporosis (Forearm)
0.000 0.997 0.003
M81.42 Drug-induced osteoporosis (Upper arm)
0.000 0.997 0.003
M81.41 Drug-induced osteoporosis (Shoulder region)
0.000 0.997 0.003
Y57.5 X-ray contrast media
0.003 0.997 0.000
M41.4 Neuromuscular scoliosis
0.003 0.997 0.000
M43.6 Torticollis
0.003 0.997 0.000
M43.09 Spondylolysis (Site unspecified)
0.003 0.997 0.000
M42 Spinal osteochondrosis
0.003 0.997 0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm
0.003 0.997 0.000
Y54.5 Other diuretics
0.003 0.997 0.000
I05.9 Mitral valve disease, unspecified
0.000 0.997 0.003
H44.9 Disorder of globe, unspecified
0.000 0.997 0.003
H44.8 Other disorders of globe
0.000 0.997 0.003
M43.89 Other specified deforming dorsopathies (Site unspecified)
0.002 0.997 0.000
M43.88 Other specified deforming dorsopathies (Sacral and sacrococcygeal region)
0.002 0.997 0.000
M43.87 Other specified deforming dorsopathies (Lumbosacral region)
0.002 0.997 0.000
M43.85 Other specified deforming dorsopathies (Thoracolumbar region)
0.002 0.997 0.000
M43.84 Other specified deforming dorsopathies (Thoracic region)
0.002 0.997 0.000
M43.83 Other specified deforming dorsopathies (Cervicothoracic region)
0.002 0.997 0.000
M43.82 Other specified deforming dorsopathies (Cervical region)
0.002 0.997 0.000
M43.81 Other specified deforming dorsopathies (Occipito-atlanto-axial region)
0.002 0.997 0.000
M43.80 Other specified deforming dorsopathies (Multiple sites in spine)
0.002 0.997 0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic
0.000 0.997 0.003
H44.6 Retained (old) intraocular foreign body, magnetic
0.000 0.997 0.003
H44.3 Other degenerative disorders of globe
0.000 0.997 0.003
N73.1 Chronic parametritis and pelvic cellulitis
0.000 0.997 0.003
M41.5 Other secondary scoliosis
0.003 0.997 0.000
G81.0 Flaccid hemiplegia
0.003 0.997 0.000
M40.09 Postural kyphosis (Site unspecified)
0.002 0.997 0.000
M40.08 Postural kyphosis (Sacral and sacrococcygeal region)
0.002 0.997 0.000
M40.07 Postural kyphosis (Lumbosacral region)
0.002 0.997 0.000
M40.06 Postural kyphosis (Lumbar region)
0.002 0.997 0.000
M40.05 Postural kyphosis (Thoracolumbar region)
0.002 0.997 0.000
M40.04 Postural kyphosis (Thoracic region)
0.002 0.997 0.000
M40.03 Postural kyphosis (Cervicothoracic region)
0.002 0.997 0.000
M40.02 Postural kyphosis (Cervical region)
0.002 0.997 0.000
M40.01 Postural kyphosis (Occipito-atlanto-axial region)
0.002 0.997 0.000
M40.00 Postural kyphosis (Multiple sites in spine)
0.002 0.997 0.000
M40.19 Other secondary kyphosis (Site unspecified)
0.002 0.997 0.000
M40.18 Other secondary kyphosis (Sacral and sacrococcygeal region)
0.002 0.997 0.000
M40.17 Other secondary kyphosis (Lumbosacral region)
0.002 0.997 0.000
M40.16 Other secondary kyphosis (Lumbar region)
0.002 0.997 0.000
M40.15 Other secondary kyphosis (Thoracolumbar region)
0.002 0.997 0.000
M40.14 Other secondary kyphosis (Thoracic region)
0.002 0.997 0.000
M40.13 Other secondary kyphosis (Cervicothoracic region)
0.002 0.997 0.000
M40.12 Other secondary kyphosis (Cervical region)
0.002 0.997 0.000
M40.11 Other secondary kyphosis (Occipito-atlanto-axial region)
0.002 0.997 0.000
M40.10 Other secondary kyphosis (Multiple sites in spine)
0.002 0.997 0.000
M40.39 Flatback syndrome (Site unspecified)
0.002 0.997 0.000
M40.38 Flatback syndrome (Sacral and sacrococcygeal region)
0.002 0.997 0.000
M40.37 Flatback syndrome (Lumbosacral region)
0.002 0.997 0.000
M40.36 Flatback syndrome (Lumbar region)
0.002 0.997 0.000
M40.35 Flatback syndrome (Thoracolumbar region)
0.002 0.997 0.000
M40.34 Flatback syndrome (Thoracic region)
0.002 0.997 0.000
M40.33 Flatback syndrome (Cervicothoracic region)
0.002 0.997 0.000
M40.32 Flatback syndrome (Cervical region)
0.002 0.997 0.000
M40.31 Flatback syndrome (Occipito-atlanto-axial region)
0.002 0.997 0.000
M40.30 Flatback syndrome (Multiple sites in spine)
0.002 0.997 0.000
M40.49 Other lordosis (Site unspecified)
0.002 0.997 0.000
M40.48 Other lordosis (Sacral and sacrococcygeal region)
0.002 0.997 0.000
M40.47 Other lordosis (Lumbosacral region)
0.002 0.997 0.000
M40.46 Other lordosis (Lumbar region)
0.002 0.997 0.000
M40.45 Other lordosis (Thoracolumbar region)
0.002 0.997 0.000
M40.44 Other lordosis (Thoracic region)
0.002 0.997 0.000
M40.43 Other lordosis (Cervicothoracic region)
0.002 0.997 0.000
M40.42 Other lordosis (Cervical region)
0.002 0.997 0.000
M40.41 Other lordosis (Occipito-atlanto-axial region)
0.002 0.997 0.000
M40.40 Other lordosis (Multiple sites in spine)
0.002 0.997 0.000
M41.49 Neuromuscular scoliosis (Site unspecified)
0.003 0.997 0.000
C32.1 Supraglottis
0.000 0.997 0.002
M41.8 Other forms of scoliosis
0.003 0.997 0.000
O32.4 Maternal care for high head at term
0.000 0.997 0.003
S80.8 Other superficial injuries of lower leg
0.003 0.997 0.000
C32.9 Larynx, unspecified
0.000 0.997 0.002
H44.5 Degenerated conditions of globe
0.000 0.997 0.002
O21.9 Vomiting of pregnancy, unspecified
0.003 0.997 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.003 0.997 0.000
M43.29 Other fusion of spine (Site unspecified)
0.002 0.997 0.000
C02.4 Lingual tonsil
0.003 0.997 0.000
N73.9 Female pelvic inflammatory disease, unspecified
0.000 0.997 0.003
Y45.2 Propionic acid derivatives
0.003 0.997 0.000
M40.59 Lordosis, unspecified (Site unspecified)
0.002 0.997 0.000
M40.58 Lordosis, unspecified (Sacral and sacrococcygeal region)
0.002 0.997 0.000
M40.57 Lordosis, unspecified (Lumbosacral region)
0.002 0.997 0.000
M40.55 Lordosis, unspecified (Thoracolumbar region)
0.002 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.